Marcie A. Goldstein

Davis Polk advised the underwriters in connection with an initial public offering of 5,750,000 shares of common stock of IDEAYA Biosciences, Inc. at $10.00 per share (which includes the…

Davis Polk advised the joint book-running managers in connection with the secondary offering of 15,000,000 shares of common stock of SolarWinds Corporation by certain of SolarWinds’…

Davis Polk advised the initial purchasers on a Rule 144A/Regulation S debt offering by Carvana Co. of $250 million aggregate principal amount of its 8.875% senior notes due 2023. Davis Polk…

Davis Polk advised the representatives of the several underwriters in connection with a $207 million initial public offering of common stock of Fastly, Inc. Fastly’s common stock is listed…

Davis Polk advised the sole bookrunner in connection with the $106.48 million SEC-registered secondary offering of 8,000,000 shares of Class A common stock of Hostess Brands, Inc. by…

Davis Polk advised the representatives of the several underwriters in connection with a $40 million initial public offering of common stock of Applied Therapeutics, Inc. Applied…

Davis Polk advised the underwriters in connection with the $8.1 billion initial public offering of 180,000,000 shares of common stock of Uber Technologies, Inc. Uber’s common stock is…

Davis Polk advised the underwriters in connection with an initial public offering of 7,521,394 shares of common stock of NGM Biopharmaceuticals, Inc. at $16.00 per share, for gross proceeds…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $64.8 million follow-on offering of common stock of Magenta Therapeutics,…

Davis Polk advised the representatives of the underwriters in connection with the $104.7 million initial public offering of 6,543,500 shares of common stock of TransMedics Group, Inc.,…